SCHEMBL7019128

SCHEMBL7019128

N#Cc1c(N)nc(OCCO)c(C#N)c1-c1ccccc1F

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.79
MAPK1 P28482 1/20 0.79
HSD17B10 Q99714 1/20 0.79
ADORA1 P30542 14/20 0.61
DHPS P49366 1/20 0.47
ADORA2A P29274 2/20 0.43
KDM4E B2RXH2 2/20 0.43
HPGD P15428 2/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SQOR Q9Y6N5 1/20 0.42
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
DYRK1A Q13627 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
STAT6 P42226 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7022142 0.86 ALDH1A1 (0.76) ALDH1A1MAPK1HSD17B10ADORA1DHPS
SCHEMBL7016201 0.84 ADORA1 (0.68) ALDH1A1MAPK1HSD17B10ADORA1ADORA2A
SCHEMBL7022379 0.83 ALDH1A1 (0.71) ALDH1A1MAPK1HSD17B10ADORA1ADORA2A
SCHEMBL7016411 0.83 ALDH1A1 (0.71) ALDH1A1MAPK1HSD17B10ADORA1ADORA2A
SCHEMBL7016509 0.82 ALDH1A1 (0.70) ALDH1A1MAPK1HSD17B10ADORA1ADORA2A
SCHEMBL7018672 0.81 ALDH1A1 (0.72) ALDH1A1MAPK1HSD17B10ADORA1ADORA2A
SCHEMBL7016245 0.81 ALDH1A1 (0.67) ALDH1A1MAPK1HSD17B10ADORA1ADORA2A
SCHEMBL7024723 0.81 ALDH1A1 (0.67) ALDH1A1MAPK1HSD17B10ADORA1ADORA2A
SCHEMBL26632985 0.79 ADORA1 (0.61) ALDH1A1MAPK1HSD17B10ADORA1ADORA2A
SCHEMBL7024980 0.78 ALDH1A1 (0.67) ALDH1A1MAPK1HSD17B10ADORA1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030232860-A1 Medicine comprising dicyanopyridine derivative ASTELLAS PHARMA INC. (JP) 2003-12-18 US disclosed
EP-1302463-A1 MEDICINE COMPRISING DICYANOPYRIDINE DERIVATIVE YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2003-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232860-A1 Medicine comprising dicyanopyridine derivative KCNN3, KCNN2, KCNN1 ALDH1A1 3292/4885MAPK1 2493/4885HSD17B10 3642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.